xyntha 250 i.u. lyophilized powder vial
زينثا 250 وحدة دولية باودر فيال
blood-coagulation factor viiiThe published official price. Pharmacies may differ slightly.
- Strength
- 250 i.u
- Form
- powder
- Manufacturer
- wyeth pharmaceuticals company > pfizer scientific office
- Route
- injection
The medical information below is guidance and may be incomplete or wrong. Do not change your medicine or dose based on it — ask a pharmacist or doctor.
Uses
Used for prevention and treatment of bleeding episodes in patients with hemophilia A.
Do not use if
Contraindicated in patients with known hypersensitivity to factor VIII products or formulation components.
Side effects
Injection-site reactions, headache, fever, hypersensitivity reactions, and inhibitor development may occur.
Warnings
Monitor for hypersensitivity reactions and development of factor VIII inhibitors.
How it works
Replacement therapy that restores deficient coagulation factor VIII activity and promotes normal clot formation.
Storage
Store refrigerated according to manufacturer instructions.